News Daily News Nuevos Hallazgos sobre la Trombosis de la Válvula Bioprotésica Tienen Implicaciones en Materia de Vigilancia e Investigación Caitlin E. Cox November 23, 2015
News Industry News Boston Scientific Receives CE Mark For Next Generation WATCHMAN FLX™ Left Atrial Appendage Closure Device November 19, 2015
News Conference News AHA 2015 Reversal Agents Safely Stop Effects of Novel Oral Anticoagulants Yael L. Maxwell November 10, 2015
News Conference News AHA 2015 DAPT Score Provides ‘Personalized Medicine’ Tool for Determining Whether to Extend Therapy Beyond 1 Year Yael L. Maxwell November 09, 2015
News Daily News Endovascular Therapy Beats Thrombolysis for Improving Function After Stroke L.A. McKeown November 03, 2015
News Daily News El Tratamiento Endovascular Supera a la Trombolisis Mejorando la Funcionalidad Post-ACV L.A. McKeown November 03, 2015
News Daily News First NOAC Antidote, Idarucizumab, Approved; Likely Won’t Hold Up Interventions Todd Neale October 26, 2015
News Daily News Aprobado el Idarucizumab, Primer Antídoto de NOAC; El Deseo es no Demorar las Intervenciones Todd Neale October 26, 2015
News Industry News FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa October 20, 2015
News Industry News Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients October 15, 2015
News Conference News TCT 2015 BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR Yael L. Maxwell October 15, 2015
News Conference News TCT 2015 Discussion Highlights Merits, Limitations of Small Trials Yael L. Maxwell October 13, 2015
News Conference News TCT 2015 LAA Closure Trials Illustrate Evolution of Devices, Trial Design October 12, 2015
News Conference News TCT 2015 Use of LAA Occlusion in Low-Risk Patients Debated Todd Neale October 11, 2015